ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Revvity Inc.

Revvity Inc. (PKN)

98,82
0,00
( 0,00% )
Mis à jour : 19:00:03

Revvity Inc. (PKN) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
98,82
( - )
Prix Achat
98,58
Prix Vente
99,12
Volume échangé
0,00
Volume moyen (3 m)
1 431 708 €
Volume financier
-
0,00 Fourchette du Jour 0,00
69,64 Plage de 52 semaines 100,80
Cap du marché
Valeur d'Entreprise
15,181B
Clôture Veille
98,82
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
VWAP
-
Chiffre d'affairess (LTM)
2,9B
Bénéfice net (LTM)
239,68M
Actions en circulation
111 559 773
Flottant (%)
91,56%
Détention Institutionnelle (%)
105,04%
Rendement du Dividende (LTM)
0,28 (0,29%)
Ratio Cours sur Bénéfices
54,46
Ratio Cours/Ventes (P/S)
4,37
Bénéfice par action (BPA)
2,1
Bêta
1,09

À propos de Revvity Inc.

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early ... Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. Show more

Secteur
-
Industrie
-
Site Web
Siège social
Waltham, United States
Fondé
2026
Revvity Inc. est coté dans le secteur de la Tradegate (DE) avec le ticker PKN. Le dernier cours de clôture d'Revvity était de 98,82 €. Au cours de la dernière année, les actions de Revvity ont été négociées dans une fourchette de prix de 69,64 € à 100,80 €.

Revvity compte actuellement 111 559 773 actions en circulation. La capitalisation boursière d'Revvity est de 11,02 € milliard. Revvity a un ratio cours/bénéfice (ratio PE) de 54.46.

PKN Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.12-0.12128562765398.9499.9696.74697.82231884DE
411.1412.705291970887.6899.9686.14792.47193662DE
1219.1624.052221943379.6699.96704987.77437255DE
268.829.890100.8706685.45801122DE
521011.258725512388.82100.869.647782.62993727DE
156-10.43-9.54691075515109.25122.6569.6411390.57965707DE
260-10.43-9.54691075515109.25122.6569.6411390.57965707DE

PKN - Frequently Asked Questions (FAQ)

What is the current Revvity Inc. share price?
The current share price of Revvity Inc. is 98,82 €
How many Revvity Inc. shares are in issue?
Revvity Inc. has 111 559 773 shares in issue
What is the market cap of Revvity Inc.?
The market capitalisation of Revvity Inc. is EUR 11,02B
What is the 1 year trading range for Revvity Inc. share price?
Revvity Inc. has traded in the range of 69,64 € to 100,80 € during the past year
What is the PE ratio of Revvity Inc.?
The price to earnings ratio of Revvity Inc. is 54,46
What is the cash to sales ratio of Revvity Inc.?
The cash to sales ratio of Revvity Inc. is 4,37
What is the registered address of Revvity Inc.?
The registered address for Revvity Inc. is 77 4th Avenue, Waltham, Massachusetts, 02451
What is the Revvity Inc. website address?
The website address for Revvity Inc. is www.revvity.com

PKN Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion